Gohel Manisha Kalpesh, Prajapati Jashbhai B, Mudgal Sreeja V, Pandya Himanshu V, Singh Uday Shankar, Trivedi Sunil S, Phatak Ajay G, Patel Rupal M
Associate Professor, Department of Community Medicine, Pramukhswami Medical College , Karamsad, India .
Professor and Head, Department of Dairy Microbiology, SMC College of Dairy Science Anand Agricultural University , Anand, India .
J Clin Diagn Res. 2016 Apr;10(4):LC05-9. doi: 10.7860/JCDR/2016/18877.7627. Epub 2016 Apr 1.
Probiotics are live microorganisms which when administered in adequate amounts confer a health benefit on the host. Sufficient calcium intake has been reported to support bone growth and prevent bone loss during the ageing process.
To determine the effect of Lactobacillus helveticus MTCC 5463 probiotic dietary intervention on serum calcium & haematological parameters in geriatric population.
Healthy volunteers with age ranging from 64-74 years were recruited from the nearby residential areas in and around Anand, Gujarat. Study duration was from 2012 to 2015. Of the 112 subjects initially enrolled in the trial, 36 withdrew before the intervention because of not matching with criterias. Of the 76 participants, 5 subjects (4%) under test group and 12 subjects (11%) under placebo left the study. We had 59 subjects who successfully completed a double blind cross over trial. Probiotic fermented milk products (in form of "Lassi") was prepared by supplementing toned milk with honey and fermenting with probiotic Lactobacillus helveticus MTCC 5463 and Streptococcus thermophilus MTCC 5460. The final product had at least 10(8) CFU/ml of viable Lactobacillus helveticus MTCC 5463 at the time of feeding. During feeding period, 200 ml of fermented product containing the test strain to one group and a similar product but without the test strain as placebo were fed regularly at the time of breakfast in morning for 4 weeks. Subjects of each group were given a washout period of 4 weeks before they were crossed over and included to the other group. The study was approved by institutional ethics committee.
The socio-demographic and clinical profiles were similar at baseline. The mean (SD) calcium level improved significantly in test {9.36 (0.45) vs 8.45 (0.61), p<0.001}. No significant effect was observed with respect to haemoglobin & haematological parameters.
The well-documented probiotic Lactobacillus helveticus MTCC 5463 confirmed increase in serum calcium level but no effect on haematological parameters when administered to geriatrics.
益生菌是一类活的微生物,当摄入足够量时能对宿主产生健康益处。据报道,充足的钙摄入有助于骨骼生长并预防衰老过程中的骨质流失。
确定瑞士乳杆菌MTCC 5463益生菌饮食干预对老年人群血清钙和血液学参数的影响。
从古吉拉特邦阿南德及其周边地区的附近居民区招募年龄在64 - 74岁之间的健康志愿者。研究时间为2012年至2015年。最初纳入试验的112名受试者中,有36人因不符合标准在干预前退出。在76名参与者中,试验组有5名受试者(4%)和安慰剂组有12名受试者(11%)退出研究。我们有59名受试者成功完成了双盲交叉试验。益生菌发酵奶制品(“拉西”形式)是通过在低脂牛奶中添加蜂蜜并用益生菌瑞士乳杆菌MTCC 5463和嗜热链球菌MTCC 5460发酵制备而成。最终产品在喂食时每毫升至少含有10(8) CFU的活性瑞士乳杆菌MTCC 5463。在喂食期间,一组每天早餐时定期喂食200毫升含有试验菌株的发酵产品,另一组喂食类似但不含试验菌株的产品作为安慰剂,持续4周。每组受试者在交叉到另一组之前有4周的洗脱期。该研究得到了机构伦理委员会的批准。
基线时社会人口统计学和临床特征相似。试验组的平均(标准差)钙水平显著改善{9.36(0.45) 对 8.45(0.61),p<0.001}。在血红蛋白和血液学参数方面未观察到显著影响。
充分记录的益生菌瑞士乳杆菌MTCC 5463证实,给予老年人时可使血清钙水平升高,但对血液学参数无影响。